Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua A Bell

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Lancet Regional Health. Europe|July 14, 2022
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization studyJoshua A Bell, Tom G Richardson, Qin Wang, et al.
International Journal of Obesity (2005)|July 6, 2021
Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimatesLucy J Goudswaard, Joshua A Bell, David A Hughes, et al.
The Journal of Knee Surgery|June 10, 2022
Should an Age Cutoff Be Considered for Elective Total Knee Arthroplasty Patients? An Analysis of Operative Success Based on Patient-Reported OutcomesJoshua A Bell, Ahmed K Emara, Wael K Barsoum, et al.
Elife|December 21, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline Bull, Emma Hazelwood, Joshua A Bell, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline J Bull, Emma Hazelwood, Joshua A Bell, et al.
BMC Medicine|January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization studyNikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
Elife|January 25, 2022
Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisationSusan Martin, Jessica Tyrrell, E Louise Thomas, et al.
The Lancet. Public Health|June 20, 2017
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and EuropeMika Kivimäki, Eeva Kuosma, Jane E Ferrie, et al.
The Lancet. Public Health|September 5, 2018
Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort studySolja T Nyberg, G David Batty, Jaana Pentti, et al.
Cancer Causes & Control : CCC|March 11, 2022
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancerKaitlin H Wade, James Yarmolinsky, Edward Giovannucci, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Lancet Regional Health. Europe|July 14, 2022
Effects of general and central adiposity on circulating lipoprotein, lipid, and metabolite levels in UK Biobank: A multivariable Mendelian randomization studyJoshua A Bell, Tom G Richardson, Qin Wang, et al.
International Journal of Obesity (2005)|July 6, 2021
Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimatesLucy J Goudswaard, Joshua A Bell, David A Hughes, et al.
The Journal of Knee Surgery|June 10, 2022
Should an Age Cutoff Be Considered for Elective Total Knee Arthroplasty Patients? An Analysis of Operative Success Based on Patient-Reported OutcomesJoshua A Bell, Ahmed K Emara, Wael K Barsoum, et al.
Elife|December 21, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline Bull, Emma Hazelwood, Joshua A Bell, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomizationCaroline J Bull, Emma Hazelwood, Joshua A Bell, et al.
BMC Medicine|January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization studyNikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
Elife|January 25, 2022
Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisationSusan Martin, Jessica Tyrrell, E Louise Thomas, et al.
The Lancet. Public Health|June 20, 2017
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and EuropeMika Kivimäki, Eeva Kuosma, Jane E Ferrie, et al.
The Lancet. Public Health|September 5, 2018
Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort studySolja T Nyberg, G David Batty, Jaana Pentti, et al.
Cancer Causes & Control : CCC|March 11, 2022
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancerKaitlin H Wade, James Yarmolinsky, Edward Giovannucci, et al.
Pageof 6